Mass producing growth factor using adipose derived adult stem cells
View Patent ↗The present invention relates to a method for producing large amounts of human growth factors from human adipose-derived stem cells. More specifically, the invention provides a method capable of synthesizing human growth factors in significantly large amounts by culturing adipose-derived stem cells extracted from human adipose cells in suitable media and conditions. Also, stem cell culture media produced according to the method of the invention, and human growth factors isolated from the culture media, can be advantageously used as raw materials for drugs and cosmetics.
1. A method for producing medium containing a basic fibroblast growth factor (bFGF), comprising the steps of:
(i) isolating adult stem cells from mammalian adipose tissue;
(ii) culturing said cells in a serum medium, and then subculturing said cells in a serum-free medium; and
(iii) irradiating said cells with UV light, replacing the medium with a medium containing optimized concentrations of vitamins A, B, C and D, and then culturing said cells in the replaced medium in a condition of low-oxygen stimulation at 1-5% 0 2 ,
wherein the medium contains bFGF secreted from the adult stem cells.
2. A method for producing medium containing a vascular endothelial growth factor (VEGF), comprising the steps of:
(i) isolating adult stem cells from mammalian adipose tissue;
(ii) culturing said cells in a serum medium, and then subculturing said cells in a serum-free medium; and
(iii) irradiating said cells with UV light, applying a scratch stimulation to said cells, replacing the medium with a medium containing optimized concentrations of vitamins A, B, C and D, and then culturing said cells in the replaced medium in a condition of low-oxygen stimulation at 1-5% 0 2 ,
wherein the medium contains VEGF secreted from the adult stem cells.
3. A method for producing medium containing human growth factors, comprising the steps of:
(i) isolating adult stem cells from mammalian adipose tissue;
(ii) culturing said cells in a serum medium, and then subculturing said cells in a serum-free medium; and
(iii) irradiating said cells with UV light, replacing the medium with a medium containing optimized concentrations of vitamins A, B, C and D, and then culturing said cells in the replaced medium in a condition of low-oxygen stimulation at 1-5% 0 2 ,
wherein the medium contains human growth factors secreted from the adult stem cells.